Pharmena S.A. (WSE:PHR) announced a private placement of series F shares at not more than PLN 13.1 per share on October 9, 2020. The transaction may include participation from existing investor Pelion S.A. The company’s board of directors has approved the transaction. The transaction is subject approval of shareholders, which will held on November 5, 2020.